Kodiak Sciences Inc (KOD)

Currency in USD
37.000
-2.760(-6.94%)
Closed·
37.460+0.460(+1.24%)
·
Unusual trading volume
Trading near 52-week High
KOD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
36.91045.600
52 wk Range
1.92045.600
Key Statistics
Prev. Close
39.76
Open
41.89
Day's Range
36.91-45.6
52 wk Range
1.92-45.6
Volume
5.26M
Average Volume (3m)
993.6K
1-Year Change
1,171.4777%
Book Value / Share
0.45
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KOD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
51.667
Upside
+39.64%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Kodiak Sciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company’s preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), an unconjugated bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Kodiak Sciences Inc SWOT Analysis


Pipeline Promise
Explore Kodiaq Sciences' diverse eye disease treatment portfolio, including KSI-101, tarcocimab, and KSI-501, with key trial results expected in 2025-2026
Financial Hurdles
Delve into the company's financial challenges, with negative EPS forecasts and a declining stock price, balanced against its cash-rich balance sheet
Market Positioning
Learn how Kodiaq Sciences aims to differentiate itself in the competitive biotech sector through innovative treatments and a new wearable OCT device
Future Outlook
Analyst price targets range from $3 to $4, reflecting cautious optimism amid clinical trial uncertainties and potential market opportunities
Read full SWOT analysis

Compare KOD to Peers and Sector

Metrics to compare
KOD
Peers
Sector
Relationship
P/E Ratio
−10.6x−3.9x−0.4x
PEG Ratio
0.810.020.00
Price/Book
96.8x4.0x2.6x
Price / LTM Sales
-20.6x3.1x
Upside (Analyst Target)
54.1%199.3%58.6%
Fair Value Upside
Unlock0.9%8.2%Unlock

Analyst Ratings

6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 51.667
(+39.64% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Buy80.00+116.22%50.00Maintain27/03/2026
H.C. Wainwright
Buy58.00+56.76%38.00Maintain27/03/2026
Jefferies
Buy56.00+51.35%39.00Maintain26/03/2026
H.C. Wainwright
Buy38.00+2.70%-Maintain10/02/2026
H.C. Wainwright
Buy38.00+2.70%26.00Maintain22/01/2026

Earnings

Latest Release
13/11/2025
EPS / Forecast
-1.16 / -1.02
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

9.60
RLAY
-5.14%
17.610
UGRO
-37.11%
2.020
OLPX
+0.50%
2.2700
SER
-13.03%
38.830
ELVN
-1.17%

FAQ

What Is the Kodiak Sciences (KOD) Share Price Today?

The Kodiak Sciences stock price today is 37.000 USD.

What Stock Exchange Does Kodiak Sciences (KOD) Trade On?

Kodiak Sciences is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Kodiak Sciences?

The stock symbol (also called a 'ticker') for Kodiak Sciences is "KOD."

What Is the Current Kodiak Sciences Market Cap?

As of today, Kodiak Sciences market cap is 2.290B USD.

What Is Kodiak Sciences's (KOD) Earnings Per Share (TTM)?

The Kodiak Sciences EPS is currently -4.119 (Trailing Twelve Months).

When Is the Next Kodiak Sciences Earnings Date?

Kodiak Sciences's next earnings report will be released on 30/03/2026.

Is KOD a Buy or Sell From a Technical Analyst Perspective?

Based on today's Kodiak Sciences moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Kodiak Sciences Stock Split?

Kodiak Sciences has split 0 times. (See the KOD stock split history page for full effective split date and price information.)

How Many Employees Does Kodiak Sciences Have?

Kodiak Sciences has 123 employees.

What is the current trading status of Kodiak Sciences (KOD)?

As of 28/03/2026, Kodiak Sciences (KOD) is trading at a price of 37.000 USD, with a previous close of 39.760 USD. The stock has fluctuated within a day range of 36.910 USD to 45.600 USD, while its 52-week range spans from 1.920 USD to 45.600 USD.

What Is Kodiak Sciences (KOD) Price Target According to Analysts?

The average 12-month price target for Kodiak Sciences is 51.667 USD, with a high estimate of 80 USD and a low estimate of 14 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +39.64% Upside potential.

What Is the KOD Premarket Price?

KOD's last pre-market stock price is 41.600 USD. The pre-market share volume is 92,730.000, and the stock has decreased by 1.840, or 4.630%.

What Is the KOD After Hours Price?

KOD's last after hours stock price is 37.460 USD, the stock has decreased by 0.460, or 1.240%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.